Mestag Therapeutics Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Mestag Therapeutics, based in London, England, focuses on the interactions between fibroblasts and the immune system to develop treatments for inflammatory diseases and cancer. By applying insights from fibroblast immunology, the company is developing a pipeline of first-in-class antibody programs and targets for novel therapies. As a small to mid-sized biotechnology firm, Mestag collaborates with global partners to identify therapeutic targets in its areas of focus. In 2026, the company reported progress toward clinical development of its lead program MST-0312. It has collaborations with Johnson & Johnson and MSD to identify targets in inflammatory diseases, and it participates in scientific conferences to share its work.